A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
National Institutes of Health Clinical Center (CC)
Bayer
Actuate Therapeutics Inc.
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Institut Bergonié
ViroMissile, Inc.
Dana-Farber Cancer Institute
Essen Biotech
Angiex, Inc.
MacroGenics
City of Hope Medical Center
Var2 Pharmaceuticals
Mayo Clinic
Degron Therapeutics Co.
Bristol-Myers Squibb
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
City of Hope Medical Center
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Sensei Biotherapeutics, Inc.
Lantheus Medical Imaging
Jonsson Comprehensive Cancer Center
University of Pittsburgh
NextPoint Therapeutics, Inc.
Cancer Research UK
OncoC4, Inc.
ADC Therapeutics S.A.
Gustave Roussy, Cancer Campus, Grand Paris
Esperas Pharma Inc.
Elevation Oncology
Stanford University
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
Stanford University
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Rain Oncology Inc
Peking University
European Organisation for Research and Treatment of Cancer - EORTC
NantCell, Inc.
Zhejiang Provincial People's Hospital
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute